Skip to content

LIDDS participates in BIO International Convention 2022

UPPSALA, SWEDEN – LIDDS AB (publ) announces today that the company's CEO Nina Herne and CSO Matthew Lindon will participate in the Biotech International Convention, also known as US BIO, between 13 and 16 June 2022.

LIDDS’ CEO Nina Herne and CSO Matthew Lindon participate in the US BIO, which is physically organized in San Diego, California after two years of digital events. US BIO is the world's largest meeting place for companies in the pharmaceutical and biotechnology sectors and provides opportunities for both collaboration and partner discussions as well as investor meetings. In total, more than 3,000 companies from more than 30 countries participate.